Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (A…

Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more

Ankyra Therapeutics, IncNCT06171750